Most noninvasive brain scanning systems use continuous-wave fNIRS, where the tissue is irradiated by a constant stream of photons. However, these systems cannot differentiate between scattered and ...
Ever wondered what’s going on inside somebody’s head? Us too, and it might just be possible to see inside another person’s brain outside a laboratory setting soon. Earlier this year, US startup Kernel ...
LOS ANGELES--(BUSINESS WIRE)--Kernel, a leader in non-invasive neuroimaging, announces the publication of their study "Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics ...
Your Brain On Drugs: Psychedelic therapeutics company Cybin and neuroimaging tech startup Kernel will study patients' brains while on ketamine. The U.S. Food and Drug Administration has approved a ...
- Results to be presented at PSYCH Symposium taking place in London on May 11, 2022 - LOS ANGELES & TORONTO--(BUSINESS WIRE)--Kernel, a leader in non-invasive neuroimaging, and Cybin Inc. (NEO:CYBN) ...
Ketamine has been the subject of research in recent years, highlighting its potential to treat and cure depression. The U.S. Food and Drug Administration (FDA) authorized Kernel, a neurotech company ...
In the midst of a global COVID-19 pandemic, entrepreneur Bryan Johnson quietly launched a new neurotechnology paradigm that may shift how neuroscience researchers conduct brain studies in the future.
Recent advances in brain imaging techniques facilitate accurate, high-resolution observations of the brain and its functions. For example, functional near-infrared spectroscopy (fNIRS) is a widely ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results